Logistics & Planning Associate II

The role

The Logistics and Planning Associate II will coordinate supply planning and logistics activities across multiple clinical studies. This role supports Iovance Biotechnologies goals and objectives through scheduling, courier management, and cross-functional collaboration.

What you will do

• Assist in the implementation of scheduling software program for clinical trials and commercial requirements.
• Work with Clinical, Manufacturing, and CMOs to develop logistic support for production plans and patient schedules.
• Support Clinical Operations with new site onboarding.
• Implement key performance measures to improve product transport and on-time delivery.
• Manage the sourcing, onboarding, performance and relationship of logistics couriers.
• Collaborate in a cross-functional, team-oriented environment.
• Participate in Product/Study Teams to align demand/supply plans to program milestones.
• Prepare, review and present assigned data, reports and presentations.
• Interface with all levels of organization, including senior management.
• Deliver presentations and make recommendations to leadership.

Required qualifications

• Bachelor's degree
• 2-4 years in a related supply chain/planning/logistics role
• Ability to work with multiple databases and electronic systems
• Strong analytical and problem-solving skills
• Attention to detail
• Outstanding organizational skills
• Ability to multi-task and prioritize
• Excellent interpersonal, verbal and written communication skills
• Comfortable in a fast-paced small company environment with minimal direction
• Advanced qualitative and quantitative analytical skills
• Good business acumen including financial analysis
• Skilled with Microsoft Excel and PowerPoint

Nice to have

• Experience planning for time critical and temperature sensitive products
• Experience with Oracle/ERP, courier, and material ordering portals

About the company

Iovance Biotherapeutics, Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. The company operates as an end-to-end cell therapy company with centralized U.S.-based manufacturing.